Investors
Smith+Nephew is a portfolio medical technology company focused on the repair, regeneration and replacement of soft and hard tissue.
Quarterly Results
We have released our results for the fourth quarter and full year 2022 on Tuesday 21 February 2023
Smith+Nephew Q4 and Full Year results 2022 Webcast
We have released our results for the fourth quarter and full year 2022 on Tuesday 21 February 2023
This was followed by a conference call for financial analysts which is available for replay.
Investor Resources
Events
Annual General Meeting 2023
26 April 2023 Watford, UK
Event details
The Annual General Meeting (AGM) will be held at 12:00pm on Wednesday, 26 April 2023 at Smith+Nephew Academy London, Building 5, Croxley Park, Hatters Lane, Watford, WD18 8YE.
Sustainability
As a portfolio medical technology company, Smith+Nephew’s purpose is to restore and promote health and wellbeing.
We believe that this applies not just to the benefits our products deliver to patients, but also to the wider health of the planet and society.